As of Nov 19, 2026, 0 of 1 active firms rate TIL a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
TIL EPS & revenue forecast
EPS · NEXT QUARTER
—
Range — – — · 0 analysts
Next period, 0 analysts expect Instil Bio Inc. to earn — a share (range — – —), versus — a year earlier. Full-year consensus is $-1.17.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 0 analysts
Revenue is expected to reach $0 (range $0 – $0). Full-year consensus is $0, rising to $0 next year.
Top analysts covering Instil Bio Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on TIL.
#1
Mitchell Kapoor
HC Wainwright & Co. · Rank #305
Neutral
No targeton TIL
Overall win rate
33%
+ Follow
#2
Reni J. Benjamin
JMP Securities · Rank #489
Neutral
No targeton TIL
Overall win rate
29%
+ Follow
#3
JA
Jack Allen
Baird
Neutral
$7.00+28.9% to target
Coverage
—
+ Follow
#4
CM
Chris Muller
JMP Securities
Neutral
No targeton TIL
Coverage
—
+ Follow
#5
KS
Kelly Shi
Jefferies
Buy
$52.00+857.6% to target
Coverage
—
+ Follow
TIL stock forecast FAQ
Is TIL stock a Buy, Sell or Neutral right now?+
The current consensus is Insufficient coverage. Of the 1 active firms as of Nov 19, 2026, 0 rate it Buy or Strong Buy, 1 rate it Neutral, and 0 rate it Sell or Strong Sell.
How many active Wall Street firms cover TIL?+
1 active firms have a recognized rating on Instil Bio Inc. as of Nov 19, 2026.
Who is the most accurate analyst covering TIL?+
Among analysts who currently cover TIL, Mitchell Kapoor of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #305). Their current call is Neutral.
What is Instil Bio Inc.'s projected EPS for next quarter?+
The consensus estimate is — per share (range — – —) across 0 analysts. Full-year EPS is projected at $-1.17, rising to — the following year.
How much revenue is Instil Bio Inc. expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $0 next year.
Have analysts been upgrading or downgrading TIL lately?+
As of Nov 19, 2026, 0 of 1 active firms rate TIL a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their TIL calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.